We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be applied across a vast array of indications to create victories for patients most in need.
Looking for a particular Kezar Life Sciences employee's phone or email?
The Kezar Life Sciences annual revenue was $7 million in 2026.
Chris Kirk is the CEO of Kezar Life Sciences.
24 people are employed at Kezar Life Sciences.
Kezar Life Sciences is based in South San Francisco, California.